Cidara Therapeutics: $11.1M European Approval Milestone
Cidara Therapeutics receives $11.1 million milestone payment from Mundipharma for European approval of new antifungal drug, Rezzayo. Analysts see potential ...
- Latest
- Trending
Cidara Therapeutics receives $11.1 million milestone payment from Mundipharma for European approval of new antifungal drug, Rezzayo. Analysts see potential ...
The use of robotic-assisted surgery and surgical navigation techniques does not increase the risk of joint infection in total hip ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.